Catheter ablation should not be first-line therapy for atrial fibrillation
Hugh Calkins
Correspondence The Johns Hopkins Hospital, 600 North Wolfe Street, Carnegie 530, Baltimore, MD 21287, USA
Email hcalkins@jhmi.edu
Catheter ablation of atrial fibrillation is a relatively novel procedure that has rapidly become widely practiced. In this Viewpoint, Hugh Calkins highlights the potential dangers of this intervention, and cautions that it is premature to adopt catheter ablation as first-line therapy for patients with atrial fibrillation until data from large, prospective multicenter clinical trials are available.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
